Clean Science and Technology Limited — PPTs, 14-05-2026: Investor Presentation

Clean Science and Technology's Q4 FY26 consolidated revenue was INR 249 Cr, a 6% YoY decline, while full-year FY26 consolidated revenue reached INR 957 Cr, down 1% YoY. Despite challenging market conditions, EBITDA margins remained resilient, with standalone EBITDA at 45.6% for Q4 and 44.3% for FY26. Consolidated Profit After Tax for Q4 FY26 was INR 58 Cr, and for FY26, it was INR 230 Cr. HALS product sales momentum continues, and the base business shows signs of rebound.

Key strategic focus areas include significant greenfield capex to commercialize new product series and adding new chemistries and process technologies, particularly for high-value products. The company incurred ~INR 220 Cr in capex during FY26, mainly for its subsidiary Clean Fino Chem Ltd., which houses India's largest HALS facility. The Board approved a final dividend of Rs. 4 per share. The company maintains a healthy cash balance to fund ongoing capex and growth plans.